These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 18442981)
1. Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins. Chen WY; Chang FR; Huang ZY; Chen JH; Wu YC; Wu CC J Biol Chem; 2008 Jun; 283(25):17184-93. PubMed ID: 18442981 [TBL] [Abstract][Full Text] [Related]
2. Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90. Wang HC; Tsai YL; Wu YC; Chang FR; Liu MH; Chen WY; Wu CC PLoS One; 2012; 7(5):e37764. PubMed ID: 22701533 [TBL] [Abstract][Full Text] [Related]
3. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Powers MV; Clarke PA; Workman P Cancer Cell; 2008 Sep; 14(3):250-62. PubMed ID: 18772114 [TBL] [Abstract][Full Text] [Related]
4. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863 [TBL] [Abstract][Full Text] [Related]
6. X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition. Cesa LC; Shao H; Srinivasan SR; Tse E; Jain C; Zuiderweg ERP; Southworth DR; Mapp AK; Gestwicki JE J Biol Chem; 2018 Feb; 293(7):2370-2380. PubMed ID: 29255093 [TBL] [Abstract][Full Text] [Related]
7. Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo. Wang W; Liu Y; Zhao Z; Xie C; Xu Y; Hu Y; Quan H; Lou L Cancer Sci; 2016 Jun; 107(6):782-90. PubMed ID: 27002306 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells. Gu M; Yu Y; Gunaherath GM; Gunatilaka AA; Li D; Sun D Invest New Drugs; 2014 Feb; 32(1):68-74. PubMed ID: 23887853 [TBL] [Abstract][Full Text] [Related]
9. Tubocapsenolide A targets C-terminal cysteine residues of HSP90 to exert the anti-tumor effect. Zhu D; Li S; Chen C; Wang S; Zhu J; Kong L; Luo J Pharmacol Res; 2021 Apr; 166():105523. PubMed ID: 33667688 [TBL] [Abstract][Full Text] [Related]
10. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Yu Y; Hamza A; Zhang T; Gu M; Zou P; Newman B; Li Y; Gunatilaka AA; Zhan CG; Sun D Biochem Pharmacol; 2010 Feb; 79(4):542-51. PubMed ID: 19769945 [TBL] [Abstract][Full Text] [Related]
11. Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. Sarkar S; Dutta D; Samanta SK; Bhattacharya K; Pal BC; Li J; Datta K; Mandal C; Mandal C Int J Cancer; 2013 Feb; 132(3):695-706. PubMed ID: 22729780 [TBL] [Abstract][Full Text] [Related]
12. Death by chaperone: HSP90, HSP70 or both? Powers MV; Clarke PA; Workman P Cell Cycle; 2009 Feb; 8(4):518-26. PubMed ID: 19197160 [TBL] [Abstract][Full Text] [Related]
13. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer. Srirangam A; Mitra R; Wang M; Gorski JC; Badve S; Baldridge L; Hamilton J; Kishimoto H; Hawes J; Li L; Orschell CM; Srour EF; Blum JS; Donner D; Sledge GW; Nakshatri H; Potter DA Clin Cancer Res; 2006 Mar; 12(6):1883-96. PubMed ID: 16551874 [TBL] [Abstract][Full Text] [Related]
14. C0818, a novel curcumin derivative, induces ROS-dependent cytotoxicity in human hepatocellular carcinoma cells in vitro via disruption of Hsp90 function. Abdelmoaty AAA; Zhang P; Lin W; Fan YJ; Ye SN; Xu JH Acta Pharmacol Sin; 2022 Feb; 43(2):446-456. PubMed ID: 33824458 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504 [TBL] [Abstract][Full Text] [Related]
16. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex. Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248 [TBL] [Abstract][Full Text] [Related]
17. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Muller P; Ruckova E; Halada P; Coates PJ; Hrstka R; Lane DP; Vojtesek B Oncogene; 2013 Jun; 32(25):3101-10. PubMed ID: 22824801 [TBL] [Abstract][Full Text] [Related]
18. Both the N- and C-terminal chaperone sites of Hsp90 participate in protein refolding. Minami M; Nakamura M; Emori Y; Minami Y Eur J Biochem; 2001 Apr; 268(8):2520-4. PubMed ID: 11298772 [TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of methylene blue via inhibition of heat shock protein 70. Sanchala D; Bhatt LK; Pethe P; Shelat R; Kulkarni YA Biomed Pharmacother; 2018 Nov; 107():1037-1045. PubMed ID: 30257315 [TBL] [Abstract][Full Text] [Related]
20. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation. Mawatari T; Ninomiya I; Inokuchi M; Harada S; Hayashi H; Oyama K; Makino I; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T Int J Oncol; 2015 Dec; 47(6):2073-81. PubMed ID: 26497673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]